Market Cap 105.37M
Revenue (ttm) 3.55M
Net Income (ttm) -14.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -419.15%
Debt to Equity Ratio 0.00
Volume 1,122,000
Avg Vol 159,570
Day's Range N/A - N/A
Shares Out 16.73M
Stochastic %K 24%
Beta 0.19
Analysts Strong Sell
Price Target $16.20

Company Profile

Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary therapies to enhance the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. It develops COYA 302, a biologic combination for subcutaneous administration intended to enhance Treg function while depleting T effector function and activated macrophages in Phase...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 587 8170
Address:
5850 San Felipe St., Suite 500, Houston, United States
BioTechHealthX
BioTechHealthX Oct. 26 at 6:48 AM
$COYA Coya Therapeutics' breakthrough ALS and Alzheimer’s drug platform positions it for potential multi-bagger gains. https://biotechhealthx.com/biotech-news/coya-therapeutics-coya-could-be-the-next-5x-biotech/
0 · Reply
Jwa68
Jwa68 Oct. 24 at 5:51 PM
$COYA As expected and advised this am. Stay the course. Fair value is easily 275M in my mind curently which is around 13 to 14 a share. Target much higher with likely sale to Dr. Reddy’s next year.
1 · Reply
BigBoomer1776
BigBoomer1776 Oct. 24 at 5:43 PM
$COYA Amazing recovery following the offering. Im guessing a few big boys have started to turn their heads our way...
1 · Reply
vo2macs
vo2macs Oct. 24 at 4:18 PM
$COYA So, at mid day, volume is 6x normal, and shares are being bought up $1 higher than the $5.50 offering. What would a smart investor do in this scenario? I know what I'm doing...
1 · Reply
microcapspeculator
microcapspeculator Oct. 24 at 4:17 PM
$COYA Deal will close on Monday and if we hear who is in deal the stock will bounce much higher. Should also get info on dosing of patients and next payment from partner Dr Reddy.
0 · Reply
topstockalerts
topstockalerts Oct. 24 at 2:06 PM
Shares of Coya Therapeutics Inc fell in premarket trading Friday after the clinical-stage biotech firm priced its public offering of common stock. The company is offering 3,636,364 shares at $5.50 each, aiming to raise about $20 million in gross proceeds before underwriting discounts, commissions, and expenses. Coya also granted the underwriter a 30-day option to purchase up to 545,454 additional shares at the same price. Coya Therapeutics, which develops biologics to enhance regulatory T-cell function for neurodegenerative diseases, plans to use the net proceeds for working capital, general corporate purposes, and clinical development funding. Lucid Capital Markets is acting as sole bookrunner, and Allele Capital Partners, through its broker-dealer Wilmington Capital Securities, is serving as financial advisor. The offering is expected to close on or around October 27, 2025, subject to customary conditions. $COYA
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 24 at 12:48 PM
$COYA (-10.5% pre) Coya Therapeutics prices $20 million public offering at $5.50 per share https://ooc.bz/l/81792
0 · Reply
Jwa68
Jwa68 Oct. 24 at 12:47 PM
$COYA Looks like my 20k buy order at 6 may not happen. Apparently some have the same idea.
0 · Reply
microcapspeculator
microcapspeculator Oct. 24 at 12:33 PM
$COYA If 4m shares changes how you feel about what COYA can do you should sell. This marks the bottom going forward.
1 · Reply
Orlandotrader
Orlandotrader Oct. 24 at 12:24 PM
$COYA Offering 5.50. Gonna wait for 5$. Inevitably Most times will trade below offering price. Will look to add at 5$. Had 6$ post market yesterday and bailed when I found out this was being offered 1.50 below yesterday closing price. Fire sale.
0 · Reply
Latest News on COYA
Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD

Feb 7, 2025, 5:17 PM EST - 9 months ago

Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD


Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off

Oct 31, 2024, 10:31 AM EDT - 1 year ago

Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off


Coya Therapeutics Announces $10.0 Million Private Placement

Oct 22, 2024, 9:00 AM EDT - 1 year ago

Coya Therapeutics Announces $10.0 Million Private Placement


BioTechHealthX
BioTechHealthX Oct. 26 at 6:48 AM
$COYA Coya Therapeutics' breakthrough ALS and Alzheimer’s drug platform positions it for potential multi-bagger gains. https://biotechhealthx.com/biotech-news/coya-therapeutics-coya-could-be-the-next-5x-biotech/
0 · Reply
Jwa68
Jwa68 Oct. 24 at 5:51 PM
$COYA As expected and advised this am. Stay the course. Fair value is easily 275M in my mind curently which is around 13 to 14 a share. Target much higher with likely sale to Dr. Reddy’s next year.
1 · Reply
BigBoomer1776
BigBoomer1776 Oct. 24 at 5:43 PM
$COYA Amazing recovery following the offering. Im guessing a few big boys have started to turn their heads our way...
1 · Reply
vo2macs
vo2macs Oct. 24 at 4:18 PM
$COYA So, at mid day, volume is 6x normal, and shares are being bought up $1 higher than the $5.50 offering. What would a smart investor do in this scenario? I know what I'm doing...
1 · Reply
microcapspeculator
microcapspeculator Oct. 24 at 4:17 PM
$COYA Deal will close on Monday and if we hear who is in deal the stock will bounce much higher. Should also get info on dosing of patients and next payment from partner Dr Reddy.
0 · Reply
topstockalerts
topstockalerts Oct. 24 at 2:06 PM
Shares of Coya Therapeutics Inc fell in premarket trading Friday after the clinical-stage biotech firm priced its public offering of common stock. The company is offering 3,636,364 shares at $5.50 each, aiming to raise about $20 million in gross proceeds before underwriting discounts, commissions, and expenses. Coya also granted the underwriter a 30-day option to purchase up to 545,454 additional shares at the same price. Coya Therapeutics, which develops biologics to enhance regulatory T-cell function for neurodegenerative diseases, plans to use the net proceeds for working capital, general corporate purposes, and clinical development funding. Lucid Capital Markets is acting as sole bookrunner, and Allele Capital Partners, through its broker-dealer Wilmington Capital Securities, is serving as financial advisor. The offering is expected to close on or around October 27, 2025, subject to customary conditions. $COYA
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 24 at 12:48 PM
$COYA (-10.5% pre) Coya Therapeutics prices $20 million public offering at $5.50 per share https://ooc.bz/l/81792
0 · Reply
Jwa68
Jwa68 Oct. 24 at 12:47 PM
$COYA Looks like my 20k buy order at 6 may not happen. Apparently some have the same idea.
0 · Reply
microcapspeculator
microcapspeculator Oct. 24 at 12:33 PM
$COYA If 4m shares changes how you feel about what COYA can do you should sell. This marks the bottom going forward.
1 · Reply
Orlandotrader
Orlandotrader Oct. 24 at 12:24 PM
$COYA Offering 5.50. Gonna wait for 5$. Inevitably Most times will trade below offering price. Will look to add at 5$. Had 6$ post market yesterday and bailed when I found out this was being offered 1.50 below yesterday closing price. Fire sale.
0 · Reply
mwb1
mwb1 Oct. 24 at 12:10 PM
$COYA Added this morning at $5.96
0 · Reply
foreverboner
foreverboner Oct. 24 at 11:37 AM
$COYA everything being done was inevitable and is prudent.
1 · Reply
Jwa68
Jwa68 Oct. 24 at 11:24 AM
$COYA Stock traded at $5 19 just a month ago. Recent move up on the Einhorn shareholder letter makes the discount feel larger than the actual just 15% discount to 30day VWAP. Importantly, no warrants.
1 · Reply
ap20
ap20 Oct. 24 at 11:11 AM
$COYA Added. Will return to previously scheduled liftoff next week.
0 · Reply
DonCorleone77
DonCorleone77 Oct. 24 at 10:58 AM
$COYA Coya Therapeutics 3.64M Spot Secondary priced at $5.50
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 24 at 10:56 AM
0 · Reply
Jwa68
Jwa68 Oct. 24 at 10:49 AM
$COYA Take a screen shot of the current price and remenber this day. Some of the smartest and most influential lifesci institutional investors now own Coya. Rumored to be 3x over subscribed. I expect the shares are soon possobly on their way to new 52 week highs in double digitw in upcoming monrhs. Never in its history has the stock offered better asymmetric risk, than at this very second. Follow the smart money...David Einhorn, and now some of the top institutional names in biotch. Watch those foethcoming section 13 filings.
2 · Reply
IBOTTheDipAndTheDipWon
IBOTTheDipAndTheDipWon Oct. 24 at 10:33 AM
$COYA Public offering of 3.64 million shares at 5.50. It's a good thing, right?
1 · Reply
Chrissytina
Chrissytina Oct. 24 at 12:36 AM
$COYA I wasn’t sure when I sold 1/2 of mine at $7.25 but now I wish I sold it all 🤦🏼‍♀️ I love this company it’s got a ton of upside but I can’t lie on every pump I sell some, then buy more but this time I sold half so I guess I’ll watch how low it goes and buy more! 🤷🏼‍♀️
1 · Reply
Jwa68
Jwa68 Oct. 23 at 10:59 PM
$COYA The one thing holding the company's shares back since day one was the lack of any top life science investors in the name. A lack of proper institutional sponsorship. The disparity between where it should be trading, and where it is trading is immense, and directly related to the lack thereof. I suspect that one elusive missing piece of the puzzle is now in place I suspect this was not done because they needed money, they didn't. Not out of necessity, rather out of opportunity. I believe this is yet another well executed tactical move made by management to allow some influential and well followed institutional investors to get involved. Only way you get those top lifesci names is letting them in just like this. Call it a very brief step back, in order to leap three foreward. Let's see who the investors are. The Section 13 filings should prove telling. No management team out there has their goals more alligned with its shareholders, than this team in my opinion
2 · Reply
vo2macs
vo2macs Oct. 23 at 10:08 PM
$COYA Hedge fund AH games. The prospectus dies not include the number or price of the shares.
1 · Reply
Orlandotrader
Orlandotrader Oct. 23 at 9:23 PM
$COYA I will take those Cheepies!!!!
0 · Reply